10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-026629`
Period End Date	20180930
Filing Date	20181105
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	tyme-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 40 Cash Flow Statement 38 Stockholders Equity 14

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.07M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Prepaid rent	`PrepaidRent`	$242.75K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$271.55K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$732.55K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$532.12K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.71M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$22.12M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$14.04K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$3.24K	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsNoncurrent`	$1.31M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsNoncurrent`	$1.67M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid rent, net of current portion	`PrepaidRentNoncurrent`	$222.53K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total assets	`Assets`	$24.02M	USD	Point-in-time
Total assets	`Assets`	$31.02M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	102.72M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	101.23M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	102.72M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Accounts payable and other current liabilities (including $251,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.82M	USD	Point-in-time
Accounts payable and other current liabilities (including $251,000 and $384,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.40M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.25M	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$691.37K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$155.25K	USD	Point-in-time
Insurance note payable	`NotesPayableCurrent`	$480.09K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.25M	USD	Point-in-time
Commitments and contingencies (see Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 102,723,796 and 101,226,479 issued and outstanding at September 30, 2018 and March 31, 2018, respectively	`CommonStockValue`	$10.12K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 102,723,796 and 101,226,479 issued and outstanding at September 30, 2018 and March 31, 2018, respectively	`CommonStockValue`	$10.28K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$87.33M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$79.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-66.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-52.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.77M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$31.02M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$24.02M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$565.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$651.00K	USD	2 Qtrs
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$251.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$972.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.55M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.45M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.82M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.44M	USD	1 Quarter
General and administrative (including $251,000, $565,000, $651,000 and $972,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$4.67M	USD	2 Qtrs
General and administrative (including $251,000, $565,000, $651,000 and $972,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.57M	USD	1 Quarter
General and administrative (including $251,000, $565,000, $651,000 and $972,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.74M	USD	1 Quarter
General and administrative (including $251,000, $565,000, $651,000 and $972,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$7.28M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$5.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.49M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$7.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$13.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.30M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.01M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-13.73M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-8.49M	USD	2 Qtrs
Other income	`NonoperatingIncomeExpense`	$390.38K	USD	2 Qtrs
Other income	`NonoperatingIncomeExpense`	$74.76K	USD	1 Quarter
Interest expense	`InterestExpense`	$6.06K	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.43K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.74M	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	2 Qtrs
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.65M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.28M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	101.44M	shares	2 Qtrs
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.32M	shares	1 Quarter

Cash Flow Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-13.74M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-8.10M	USD	2 Qtrs
Depreciation	`Depreciation`	$2.15K	USD	2 Qtrs
Depreciation	`Depreciation`	$4.74K	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$3.59M	USD	2 Qtrs
Amortization of employees, directors and consultants stock options	`AmortizationOfEmployeesDirectorsAndConsultantsStockOptions`	$4.70M	USD	2 Qtrs
Gain on remeasurement of derivative liability	`DerivativeGainLossOnDerivativeNet`	$390.38K	USD	2 Qtrs
Prepaid rent	`IncreaseDecreaseInPrepaidRent`	$465.28K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-200.43K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$954.57K	USD	2 Qtrs
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$634.47K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$103.40K	USD	2 Qtrs
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-416.29K	USD	2 Qtrs
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-557.32K	USD	2 Qtrs
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-10.90M	USD	2 Qtrs
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-5.74M	USD	2 Qtrs
Net cash used in operating expenses	`NetCashProvidedByUsedInOperatingActivities`	$-4.70M	USD	1 Quarter
Purchase of property & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.54K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.54K	USD	2 Qtrs
Insurance note payments	`InsuranceNotePayments`	$324.85K	USD	2 Qtrs
Proceeds from private placement offering of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfPrivatePlacement`	$2.60M	USD	2 Qtrs
Issuance of common stock from at-the-market financing	`ProceedsFromIssuanceOfCommonStock`	$3.34M	USD	2 Qtrs
Issuance of common stock from at-the-market financing	`ProceedsFromIssuanceOfCommonStock`	$32.10M	USD	Annual
Proceeds from collection of stock subscription receivable	`ProceedsFromCollectionOfStockSubscriptionReceivable`	$175.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.77M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.01M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-7.91M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.97M	USD	2 Qtrs
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$21.07M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - beginning	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$7.51M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$21.07M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$28.98M	USD	Point-in-time
Cash and cash equivalents - ending	`CashAndCashEquivalentsAtCarryingValue`	$10.48M	USD	Point-in-time
Interest	`InterestPaidNet`	$6.06K	USD	2 Qtrs
Derivative liability associated with the price protection feature of shares of common stock issued	`NonCashFairValueofDerivativeLiability`	$11.79K	USD	2 Qtrs

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.47M	USD	Point-in-time
Balance, at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.77M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	102.72M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time
Issuance of common stock from at-the-market financing facility, net of associated expenses	`StockIssuedDuringPeriodValueNewIssues`	$3.34M	USD	2 Qtrs
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.70M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.10M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-13.74M	USD	2 Qtrs
Balance, at end	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$26.47M	USD	Point-in-time
Balance, at end	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$20.77M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	102.72M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	101.23M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.